PLCG2 and Alzheimer disease: In summary, we report mechanisms whereby two SNPs alter PLCG2 expression and AD risk, test whether a novel isoform is expressed as protein, and show that PLCG2splicing can be modulated in a fashion that would reduce AD risk.